Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Patient-derived organoids reveal which breast tumors may resist standard therapies

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors.

Patient-derived organoids reveal which breast tumors may resist standard therapies

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Monday 10 August →